Form 4 for CME CME Group
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001156375-24-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-19 | 2024-03-15 | CME | Fitzpatrick Lynne | Sr MD CFO | F - Tax | $217.50 | -329 | 14.1K | -2% | -$71.6K |
| 2024-03-19 | 2024-03-15 | CME | Fitzpatrick Lynne | Sr MD CFO | A - Grant | $217.50 | +559 | 14.3K | +4% | +$121.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock Class A | 2024-03-15 | F | D | 81 | $217.50 | 14,015 | D | — | — | (F3) Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2024. |
| 2 | Common | Common Stock Class A | 2024-03-15 | A | A | 559 | $217.50 | 14,344 | D | — | — | (F1) Represents shares earned from a 2020 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2021-2023. |
| 3 | Common | Common Stock Class A | 2024-03-15 | F | D | 248 | $217.50 | 14,096 | D | — | — | (F2) Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. |